A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Conditions

• Cystic Fibrosis

Eligibility Criteria

Sex

ALL

Age

12 Years - N/A

Healthy Volunteers

Not accepted

Study Details

The REACH study is for people with CF who do not take cystic fibrosis transmembrane conductance regulator (CFTR) modulators. The goal of the REACH study is to collect research data, including health data and specimens, from people with CF who do not take CFTR modulators. This data may be used to inform CF research, help design CF clinical trials and support the development of new treatments for people with CF who do not take CFTR modulators. Another goal of this study is to learn about research involvement for people with CF who do not take CFTR modulators, engage them in research, and give them an opportunity to learn about what is involved in participating in a CF research study.

Key Dates

Start date

Sep 18, 2024

Status verified

Sep 2025

Primary completion

Aug 14, 2029

Completion

Aug 14, 2029

Study Design

Enrollment

400 participants (estimated)

Primary Outcome Measure

Change in ppFEV1 at 12 months [ Time Frame: 12 months ]

Central Contacts

• Olena Boyarska
  206-884-1681
  [email protected]
• Anna Mead
  206-884-7531
  [email protected]

Locations (68)

Find similar trials in Birmingham, AL

Related Studies

• Role of Genetic Factors in the Development of Lung Disease
  Recruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
• Natural History of Bronchiectasis
  Recruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
• Beta-cell Response to Incretin Hormones in Cystic Fibrosis
  Recruiting · University of Pennsylvania · Philadelphia, Pennsylvania
• Genetics of Insulin and Incretins in Cystic Fibrosis
  Recruiting · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania